TrumpRx Falls Short: Supermarket Promise, Boutique Reality
TrumpRx launched with great fanfare but offers only 92 brand-name drugs — less than 12% of what participating companies make.
Tag
8 articles
TrumpRx launched with great fanfare but offers only 92 brand-name drugs — less than 12% of what participating companies make.
Six months after launch, TrumpRx offers just 92 brand-name drugs — under 12% of portfolios — leaving most Americans without real savings.
China's NHSA announces 601 drugs passed formal review for the 2026 medical insurance catalog, with a 91% pass rate and expanded access for patients.
China's AI token calls lead globally for 8th week, drug trials surpass 5,000, and CAS achieves artificial cell asymmetric division breakthrough.
GSK announces its largest-ever acquisition, buying US cancer biotech Nuvalent for $10.6 billion in a major oncology push under new CEO Luke Miels.
Xinhua calls for accelerated China innovative drug development as record BD deals top $100B and AI transforms R&D, but warns of weak basic research.
Belgian Health Minister Frank Vandenbroucke refuses to reimburse weight-loss drug Wegovy, citing prohibitive costs and concerns over essential care.
Chinese biotech firms set records at ASCO 2026 with 95 abstracts and a $10.5B Pfizer-Innovent deal, fueling concerns over US drug dominance.